These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 27417014)

  • 1. Reply: Personalize and Optimize Lipid-Lowering Therapies.
    Murphy SA; Cannon CP; Blazing MA; Giugliano RP; Tershakovec AM; Braunwald E
    J Am Coll Cardiol; 2016 Jul; 68(3):326. PubMed ID: 27417014
    [No Abstract]   [Full Text] [Related]  

  • 2. Personalize and Optimize Lipid-Lowering Therapies.
    Weingärtner O; Lütjohann D; Elsässer A
    J Am Coll Cardiol; 2016 Jul; 68(3):325-326. PubMed ID: 27417013
    [No Abstract]   [Full Text] [Related]  

  • 3. Individualized lipid-lowering therapy to further reduce residual cardiovascular risk.
    Weingärtner O; Lütjohann D; Plösch T; Elsässer A
    J Steroid Biochem Mol Biol; 2017 May; 169():198-201. PubMed ID: 27215141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The short-circuit evidence on lipid-lowering drugs use in pregnancy.
    Fogacci F; Borghi C; Cicero AFG
    Atherosclerosis; 2023 Mar; 368():12-13. PubMed ID: 36754660
    [No Abstract]   [Full Text] [Related]  

  • 5. RE.: Impact of long-term lipid-lowering therapy on clinical outcomes in breast cancer.
    Harborg S; Cronin-Fenton DP; Borgquist S
    Breast Cancer Res Treat; 2019 Oct; 177(3):771-772. PubMed ID: 31270762
    [No Abstract]   [Full Text] [Related]  

  • 6. More Nuanced Guidelines for Lipid Lowering to Prevent CVD.
    Shaughnessy AF
    Am Fam Physician; 2016 Jan; 93(1):59. PubMed ID: 26760843
    [No Abstract]   [Full Text] [Related]  

  • 7. Hypolipidemic drugs in elderly subjects: Indications and limits.
    Gazzola K; Vigna GB
    Nutr Metab Cardiovasc Dis; 2016 Dec; 26(12):1064-1070. PubMed ID: 27522161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Outcomes in Trials Evaluating Lipid-Lowering Drugs.
    Butters J; Brown A; Griffith L; Kim S; Nicholls SJ
    Am J Cardiovasc Drugs; 2017 Dec; 17(6):447-452. PubMed ID: 28432573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nutraceuticals in lipid-lowering treatment: a narrative review on the role of chitosan.
    Patti AM; Katsiki N; Nikolic D; Al-Rasadi K; Rizzo M
    Angiology; 2015 May; 66(5):416-21. PubMed ID: 25037700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results of the REVEAL study. Why Should we not welcome a new lipid lowering agent?
    Masana L
    Clin Investig Arterioscler; 2017; 29(6):278-279. PubMed ID: 29173491
    [No Abstract]   [Full Text] [Related]  

  • 11. Design and rationale for the Patient and Provider Assessment of Lipid Management (PALM) registry.
    Navar AM; Wang TY; Goldberg AC; Robinson JG; Roger VL; Wilson PF; Virani SS; Elassal J; Lee LV; Webb LE; Peterson E
    Am Heart J; 2015 Nov; 170(5):865-71. PubMed ID: 26542493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid Metabolism and Emerging Targets for Lipid-Lowering Therapy.
    Gaudet D; Drouin-Chartier JP; Couture P
    Can J Cardiol; 2017 Jul; 33(7):872-882. PubMed ID: 28365054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nicotinic acid: current status in lipid management and cardiovascular disease prevention.
    Whayne TF
    Angiology; 2014 Aug; 65(7):557-9. PubMed ID: 24101713
    [No Abstract]   [Full Text] [Related]  

  • 14. Statins in coronary artery bypass grafting surgery: lipid lowering and beyond.
    Margaritis M; Antoniades C
    Expert Rev Cardiovasc Ther; 2012 Jan; 10(1):5-8. PubMed ID: 22149521
    [No Abstract]   [Full Text] [Related]  

  • 15. Preventing cardiovascular outcome in patients with renal impairment: is there a role for lipid-lowering therapy?
    Holdaas H
    Am J Cardiovasc Drugs; 2005; 5(4):255-69. PubMed ID: 15984908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Systematic Review of Cardiovascular Outcomes-Based Cost-Effectiveness Analyses of Lipid-Lowering Therapies.
    Wei CY; Quek RGW; Villa G; Gandra SR; Forbes CA; Ryder S; Armstrong N; Deshpande S; Duffy S; Kleijnen J; Lindgren P
    Pharmacoeconomics; 2017 Mar; 35(3):297-318. PubMed ID: 27785772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipidology.
    Nicholls SJ
    Cardiol Clin; 2018 May; 36(2):xiii. PubMed ID: 29609763
    [No Abstract]   [Full Text] [Related]  

  • 18. Views on lipid lowering. JUPITER seems to be bypassed.
    Murray SW
    BMJ; 2010 Oct; 341():c5835. PubMed ID: 20959303
    [No Abstract]   [Full Text] [Related]  

  • 19. Combination therapy with statins: who benefits?
    Singh A; Davidson M
    Endocrinol Metab Clin North Am; 2014 Dec; 43(4):993-1006. PubMed ID: 25432393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipids, cardiovascular disease and atherosclerosis in systemic lupus erythematosus.
    Wierzbicki AS
    Lupus; 2000; 9(3):194-201. PubMed ID: 10805487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.